|Single Pill Combinations in HIV Treatment|
|Monica Gandhi, MD, MPH, UCSF Positive Health Program at San Francisco General Hospital|
November 13, 2013
Monica Gandhi discusses the advantages and disadvantages of using single pill combinations (SPCs) for antiretroviral therapy, reviews the evidence on whether use of SPCs improves adherence and discusses studies that support the use of various co-formulations. She goes on to describe anticipated SPCs and the impact of healthcare reform and generics on the use of SPCs.
| Presenter: Monica Gandhi, MD, MPH|
Monica Gandhi, MD, is an Associate Professor of Medicine, UCSF Division of HIV/AIDS. She specializes in the care of HIV-infected women. Her research has focused on HIV/AIDS in women from the Women's Interagency HIV Study (WIHS), a large, multisite prospective cohort established in 1994 to study the natural history and clinical and laboratory findings of HIV in women in the United States.